FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and aims at treating allergic diseases. Disclosed is a composition comprising two cultures of probiotic bacteria, Lactobacillus salivarius (LS01) DSM 22775, deposited on July 23, 2009 in the German collection of microorganisms and cell cultures (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ)), and Bifidobacterium breve (BR03) DSM 16604, deposited on July 20, 2004 in German collection of microorganisms and cell cultures GmbH-DSMZ, and its use for treating allergies, atopy, allergic rhinitis, food hypersensitivity, atopic dermatitis, eczema, asthma or immunodeficiency.
EFFECT: group of inventions extends the range of therapeutic agents.
12 cl, 1 dwg, 9 tbl
